Terumo Medical Device Company Intelligence Report
 
Report

Terumo Medical Device Company Intelligence ReportMedical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation.

From:
$595
 
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Headquartered in Tokyo, Japan, Terumo Corporation is a global medical technology company that manufactures and sells a wide range of medical products and equipment. The company's products are sold in over 150 countries, supported by a worldwide network of branches and offices. Terumo has production facilities in Japan, the US, the UK, Belgium, Mexico, China, India and the Philippines.

In fiscal 2005, ended 31st March 2005, Terumo reported its eleventh consecutive year of sales growth, with revenues up by 6.9% to a record ¥233 billion (US$2.15 billion). The company also achieved record net income of ¥27.1 billion (US$253.6 million).

The company's business is classified into the following segments:

General Hospital Products, including blood transfusion systems, disposable medical equipment (such as needles and syringes), and pharmaceuticals, including nutrition and IV solutions, and pre-filled syringes. Terumo's largest business, it accounted for 54% of total sales in fiscal 2005.

Cardiac and Vascular Products, including catheter systems, cardiovascular products and vascular grafts. This segment accounted for 35% of Terumo's 2005 sales. It includes the operations of Terumo's Vascutek vascular graft business, based in the UK, and two US companies, Terumo Cardiovascular Systems and Terumo Heart. The latter was established in January 2003 in order to focus on the DuraHeart left ventricular assist system. The European launch of DuraHeart is planned for 2006.

Home Healthcare Products, including peritoneal dialysis systems, diabetes care products, blood pressure monitoring devices and other home use products such as oxygen systems, nutritional products, thermometers and sphygmomanometers. These products, sold mainly in Japan and other parts of Asia, and accounted for 11% of Terumo's sales in fiscal 2005.

Report Details:
Publisher:
Espicom
Type:
Market Briefing - February 2006
Number of pages:
109
First Publication Date:
24/2/2006
 
 
 
Copyright © Chiltern Magazine Services Ltd | Email: admin@cmsinfo.com | Tel: +(1) 508 861 0401